Search for content, post, videos

KLIFO makes strategic investment to expand its Clinical Trial Supply capacity in Denmark

The double-digit million DKK investment is to set up a new storage and CTS production facility for the pharmaceutical and biotech industries.

The expansion site is situated in the Greater Copenhagen area in Medicon Valley.

“Through this strategic investment, we are fortifying KLIFO’s foothold in the Nordics while laying a robust foundation for the future,” says Rasmus Nelund, CEO, KLIFO. “We are significantly scaling up, tripling the size of our CTS facilities and quadrupling our storage and production capacities to meet the growth we see in the clinical trial supply market in the coming years.”

Completion by mid-2025

The new facility is scheduled for completion by mid-2025, and will triple the company’s CTS footprint, increasing it from 2,000 to 6,000 square metres, it states. The new facilities will be completely functional and certified under Good Manufacturing Practices (GMP).

“This milestone underscores our deliberate commitment to expanding our flexible and tailor-made CTS solutions. When operational next year, our enhanced facilities will enable us to deliver unparalleled solutions to pharmaceutical and biotech enterprises across the Nordic and European markets,” states Christina Vinum, Vice President Clinical Trial Supply Solutions at KLIFO.

Photo of Rasmus Nelund: KLIFO